Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

120 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Feasibility and effectiveness of HCV viraemia testing at harm reduction sites in Georgia: A prospective three-arm study.
Shilton S, Markby J, Japaridze M, Chihota V, Shadaker S, Gvinjilia L, Tsereteli M, Alkhazashvili M, Butsashvili M, Stvilia K, Ruiz RJ 3rd, Asatiani A, Adamia E, Easterbrook P, Khonelidze I, Gamkrelidze A. Shilton S, et al. Among authors: gamkrelidze a. Liver Int. 2022 Apr;42(4):775-786. doi: 10.1111/liv.15191. Epub 2022 Feb 18. Liver Int. 2022. PMID: 35129278 Free PMC article.
Economic evaluation of the Hepatitis C virus elimination program in the country of Georgia, 2015 to 2017.
Tskhomelidze I, Shadaker S, Kuchuloria T, Gvinjilia L, Butsashvili M, Nasrullah M, Gabunia T, Gamkrelidze A, Getia V, Sharvadze L, Tsertsvadze T, Zarqua J, Tsanava S, Handanagic S, Armstrong PA, Averhoff F, Vickerman P, Walker JG. Tskhomelidze I, et al. Among authors: gamkrelidze a. Liver Int. 2023 Mar;43(3):558-568. doi: 10.1111/liv.15431. Epub 2022 Oct 4. Liver Int. 2023. PMID: 36129625 Free PMC article.
Three Years of Progress Toward Achieving Hepatitis C Elimination in the Country of Georgia, April 2015-March 2018.
Tsertsvadze T, Gamkrelidze A, Chkhartishvili N, Abutidze A, Sharvadze L, Kerashvili V, Butsashvili M, Metreveli D, Gvinjilia L, Shadaker S, Nasrullah M, Adamia E, Zeuzem S, Afdhal N, Arora S, Thornton K, Skaggs B, Kuchuloria T, Lagvilava M, Sergeenko D, Averhoff F. Tsertsvadze T, et al. Among authors: gamkrelidze a. Clin Infect Dis. 2020 Aug 22;71(5):1263-1268. doi: 10.1093/cid/ciz956. Clin Infect Dis. 2020. PMID: 31563938 Free PMC article.
Interim effect evaluation of the hepatitis C elimination programme in Georgia: a modelling study.
Walker JG, Kuchuloria T, Sergeenko D, Fraser H, Lim AG, Shadaker S, Hagan L, Gamkrelidze A, Kvaratskhelia V, Gvinjilia L, Aladashvili M, Asatiani A, Baliashvili D, Butsashvili M, Chikovani I, Khonelidze I, Kirtadze I, Kuniholm MH, Otiashvili D, Sharvadze L, Stvilia K, Tsertsvadze T, Zakalashvili M, Hickman M, Martin NK, Morgan J, Nasrullah M, Averhoff F, Vickerman P. Walker JG, et al. Among authors: gamkrelidze a. Lancet Glob Health. 2020 Feb;8(2):e244-e253. doi: 10.1016/S2214-109X(19)30483-8. Epub 2019 Dec 18. Lancet Glob Health. 2020. PMID: 31864917 Free PMC article.
Treatment outcomes of patients with chronic hepatitis C receiving sofosbuvir-based combination therapy within national hepatitis C elimination program in the country of Georgia.
Tsertsvadze T, Gamkrelidze A, Nasrullah M, Sharvadze L, Morgan J, Shadaker S, Gvinjilia L, Butsashvili M, Metreveli D, Kerashvili V, Ezugbaia M, Chkhartishvili N, Abutidze A, Kvaratskhelia V, Averhoff F. Tsertsvadze T, et al. Among authors: gamkrelidze a. BMC Infect Dis. 2020 Jan 10;20(1):30. doi: 10.1186/s12879-019-4741-5. BMC Infect Dis. 2020. PMID: 31924172 Free PMC article.
Screening and linkage to care for hepatitis C among inpatients in Georgia's national hospital screening program.
Shadaker S, Nasrullah M, Gamkrelidze A, Ray J, Gvinjilia L, Kuchuloria T, Butsashvili M, Getia V, Metreveli D, Tsereteli M, Tsertsvadze T, Link-Gelles R, Millman AJ, Turdziladze A, Averhoff F. Shadaker S, et al. Among authors: gamkrelidze a. Prev Med. 2020 Sep;138:106153. doi: 10.1016/j.ypmed.2020.106153. Epub 2020 May 27. Prev Med. 2020. PMID: 32473265 Free PMC article.
Blood transfusion safety in the country of Georgia: collateral benefit from a national hepatitis C elimination program.
Bloch EM, Kipiani E, Shadaker S, Alkhazashvili M, Gvinjilia L, Kuchuloria T, Chitadze N, Keating SM, Gamkrelidze A, Turdziladze A, Getia V, Nasrullah M, Averhoff F, Izoria M, Skaggs B. Bloch EM, et al. Among authors: gamkrelidze a. Transfusion. 2020 Jun;60(6):1243-1252. doi: 10.1111/trf.15815. Epub 2020 May 4. Transfusion. 2020. PMID: 32542715 Free PMC article.
High sustained viral response among HCV genotype 3 patients with advanced liver fibrosis: real-world data of HCV elimination program in Georgia.
Butsashvili M, Gvinjilia L, Kamkamidze G, Metreveli D, Dvali S, Rukhadze T, Gamkrelidze A, Nasrullah M, Shadaker S, Morgan J, Averhoff F. Butsashvili M, et al. Among authors: gamkrelidze a. BMC Res Notes. 2020 Jul 11;13(1):332. doi: 10.1186/s13104-020-05173-4. BMC Res Notes. 2020. PMID: 32653020 Free PMC article.
120 results